跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 744 条关于
“SAVA”
全部
744
临床试验
498
药物
87
机构
26
资讯
133
去年
Sava Technologies Achieves 10-Day Continuous Glucose Monitoring Milestone with Next-Generation Microsensor Platform
去年
BridgeBio's Attruby Approved for ATTR-CM, Cassava's Simufilam Fails in Alzheimer's Trial
去年
Cassava Sciences Announces Corporate Update on Alzheimer's Drug Simufilam
去年
Cassava Sciences to Provide Corporate Update on Alzheimer's Drug Simufilam
去年
Cassava Sciences Announces Corporate Update on Alzheimer's Drug Simufilam
去年
Cassava Sciences' Simufilam Maintains Safety Profile in Phase 3 Alzheimer's Trials
去年
Cassava Sciences Nears Completion of Simufilam Phase 3 Alzheimer's Trial
去年
Cassava Sciences Bolsters Commercial Strategy with Freda Nassif as Chief Commercial Officer
去年
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer Ahead of Simufilam Phase 3 Data
去年
Savara Launches Expanded Access Program for Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
第 1 页,共 14 页
上一页
下一页